샘플 요청 목록

 카트 문의
시장보고서
상품코드
1514083

피임약 시장

Contraceptives
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 218 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

피임약 시장은 2030년까지 393억 달러에 달할 전망입니다.

2023년에 257억 달러로 평가된 피임약 시장은 예측 기간 동안 복합 연간 성장률(CAGR) 6.2%로 성장하여 2030년에는 393억 달러에 이를 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 피임약은 복합 연간 성장률(CAGR) 6.7%로 성장을 지속하고, 분석 기간이 끝날 때까지 260억 달러에 달할 것으로 예측됩니다. 피임 장치 부문의 성장률은 분석 기간 동안 복합 연간 성장률(CAGR) 5.4%로 추정됩니다.

미국 시장은 67억 달러를 나타낼 전망이며, 중국은 복합 연간 성장률(CAGR) 9.7%로 성장할 것으로 예측됩니다.

미국의 피임약 시장은 2023년 67억 달러로 평가되었습니다. 세계 2위 경제대국인 중국은 2030년까지 94억 달러 규모에 이를 것으로 예측되며, 예측 기간 동안 복합 연간 성장률(CAGR) 9.7%입니다. 다른 주목할만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 복합 연간 성장률(CAGR) 각각 3.6%와 4.9%로 예측되고 있습니다. 유럽에서는 독일이 복합 연간 성장률(CAGR) 4.5%로 성장할 것으로 예측됩니다.

세계 피임약 시장 - 주요 동향과 촉진요인 요약

피임약은 배란, 수정, 착상의 정상적인 과정을 억제하여 임신을 예방하도록 설계된 의약품입니다. 경구 알약, 콘돔, 자궁내 피임기구(IUD), 임플란트, 주사제, 패치, 긴급 피임 알약 등 다양한 형태가 있습니다. 각 피임법은 개인의 건강 상태와 기호에 따라 효능 수준, 작용 시간 및 적합성이 다릅니다. 피임약 시장은 몇 가지 중요한 요인에 의해 견인되고 있습니다. 중요한 촉진요인 중 하나는 성 건강과 가족 계획에 대한 인식과 교육 증가입니다. 정부와 비정부기구(NGO)가 공중보건 캠페인과 교육 프로그램에 투자함에 따라 더 많은 개인들이 피임약의 장점과 가용성에 대해 알고 있습니다. 이러한 의식 증가는 사람들이 자신의 재생산 건강을 통제하려고 하기 때문에 더 높은 채용률로 이어집니다. 게다가 유리한 정책과 보조금의 형태로 다양한 정부로부터의 지원의 고조가 피임약을 보다 친숙하고 저렴하게 하고, 시장의 성장을 더욱 뒷받침하고 있습니다.

피임 상황은 새로운 방법의 개발과 기존 방법의 확대에 의해 항상 진화하고 있습니다. IUD나 임플란트와 같은 장시간 작용형 가역적 피임법(LARC)에 대한 수요가 높아지고 있습니다. 이 방법은 알약과 콘돔과 같은 단기 방법에 비해 효능이 높고 편의성이 높고 작용 시간이 길기 때문에 점점 인기가 높아지고 있습니다. 게다가 기술의 진보에 의해 보다 사용하기 쉽고 부작용이 적은 새롭게 개량된 피임법의 개발이 진행되고 있습니다. 예를 들어, 호르몬 패치와 질 반지의 출현은 더 유연하고 사용하기 쉽고 더 많은 사람들에게 이러한 옵션을 고려하도록 촉구합니다.

피임구의 사용은 세계적으로 증가하고 있으며 세계 재생산 건강에 긍정적인 변화를 가져오고 있습니다. 피임약 시장에서 소비자의 기호도 임신 예방 이외의 건강 혜택을 제공하는 제품으로 이동하고 있습니다. 예를 들어, 일부 피임약은 대량 출혈과 심한 경련과 같은 월경 관련 문제를 완화하도록 설계되어 사용자에게 더 매력적입니다. 게다가 전자상거래 플랫폼과 원격 의료 서비스의 출현은 피임약에 접근하고 구매하는 방법에 혁명을 일으키고 있습니다. 이러한 디지털 채널은 특히 원격지나 서비스가 충분하지 않은 지역의 사람들에게 더 높은 프라이버시, 편의성 및 접근성을 제공합니다. 그 결과 피임약 시장은 더 많은 사람들에게 퍼지도록 확장되어 지속적인 성장과 개척에 기여하고 있습니다.

조사 대상 기업 예(주목의 92사)

  • Agile Therapeutics, Inc.
  • Allergan plc
  • Ansell Limited
  • Bayer AG
  • Church & Dwight Co., Inc.
  • CooperSurgical Inc.
  • Fuji Latex Co. Ltd.
  • Janssen Pharmaceuticals, Inc.
  • Karex Berhad
  • Mankind Pharma Ltd.
  • Okamoto Industries, Inc.
  • Pfizer Inc.
  • Piramal Enterprises Ltd.
  • Reckitt Benckiser Group Plc.
  • Sagami Rubber Industries Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Thai Nippon Rubber Industry Co., Ltd.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

BJH 24.07.25

Global Contraceptives Market to Reach US$39.3 Billion by 2030

The global market for Contraceptives estimated at US$25.7 Billion in the year 2023, is expected to reach US$39.3 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Contraceptive Drugs, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$26.0 Billion by the end of the analysis period. Growth in the Contraceptive Devices segment is estimated at 5.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.7 Billion While China is Forecast to Grow at 9.7% CAGR

The Contraceptives market in the U.S. is estimated at US$6.7 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$9.4 Billion by the year 2030 trailing a CAGR of 9.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Contraceptives Market - Key Trends and Drivers Summarized

Contraceptives are medical products designed to prevent pregnancy by interfering with the normal process of ovulation, fertilization, or implantation. They come in various forms, including oral pills, condoms, intrauterine devices (IUDs), implants, injectables, patches, and emergency contraception pills. Each method offers different levels of effectiveness, durations of action, and suitability based on individual health profiles and preferences. The contraceptive market is driven by several key factors. One significant driver is the increasing awareness and education regarding sexual health and family planning. As governments and non-governmental organizations (NGOs) invest in public health campaigns and educational programs, more individuals are informed about the benefits and availability of contraceptives. This heightened awareness leads to higher adoption rates as people seek to take control of their reproductive health. Additionally, the growing support from various governments in the form of favorable policies and subsidies makes contraceptives more accessible and affordable, further boosting market growth.

The landscape of contraception is constantly evolving with the development of new methods and the extension of existing ones. There is a rising demand for long-acting reversible contraceptives (LARCs) such as IUDs and implants. These methods are becoming increasingly popular due to their high efficacy, convenience, and longer duration of action compared to short-term methods such as pills or condoms. Moreover, technological advancements are leading to the development of new and improved contraceptive options that offer better user experiences and fewer side effects. For instance, the advent of hormonal patches and vaginal rings provides more flexibility and ease of use, encouraging more individuals to consider these alternatives.

Contraceptive use is increasing worldwide, marking a positive shift in global reproductive health. Consumer preferences in the contraceptive market are also shifting towards products that offer additional health benefits beyond pregnancy prevention. For instance, some contraceptive pills are designed to alleviate menstrual-related issues such as heavy bleeding and severe cramps, making them more attractive to users. Furthermore, the rise of e-commerce platforms and telemedicine services is revolutionizing the way contraceptives are accessed and purchased. These digital channels provide greater privacy, convenience, and accessibility, particularly for individuals in remote or underserved areas. As a result, the contraceptive market is expanding to reach a broader audience, contributing to its sustained growth and development.

Select Competitors (Total 92 Featured) -

  • Agile Therapeutics, Inc.
  • Allergan plc
  • Ansell Limited
  • Bayer AG
  • Church & Dwight Co., Inc.
  • CooperSurgical Inc.
  • Fuji Latex Co. Ltd.
  • Janssen Pharmaceuticals, Inc.
  • Karex Berhad
  • Mankind Pharma Ltd.
  • Okamoto Industries, Inc.
  • Pfizer Inc.
  • Piramal Enterprises Ltd.
  • Reckitt Benckiser Group Plc.
  • Sagami Rubber Industries Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Thai Nippon Rubber Industry Co., Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Contraceptives: Transforming Birth Control, Planned Parenthood, and Women's Health
    • Contraceptives Market: Fast Facts
    • The Vital Need to Curtail the Ballooning Global Population through Birth Control:
    • Effectiveness Index of Contraceptive Methods: Brief Details of Method, Efficacy Percentage, Benefits, Risks, and Availability
    • Unmet Contraception Needs Signals Huge Market Penetration Opportunities
    • Global Population Statistics: Unfurling the Market Potential
    • Global Market Outlook
    • Contraceptives - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Condoms as a Powerful Tool against HIV/AIDS and Other STIs Witness Strong Growth in Demand
    • Condoms: Percentage Effectiveness of Protection against STDs
    • Contraceptive Innovations and Advancements: Spearheading Growth
    • Major Condom Innovations
    • Declining Prices and Increased Accessibility of Contraceptives Benefit Market Expansion
    • Rising Need to Develop Contraceptives for Men Drive Robust Research & Development
    • Evolving Designs and Features in Female Condoms Drive Surging Popularity and Growing Adoption
    • Increasing Standard of Living: A Key Growth Driver
    • Social Stigmas in Under Developed Countries Hamper Market Prospects
    • Major Hindrances for Widespread Usages of Condoms
    • Developing Countries Continue to Drive Current and Future Market Growth
    • Manufacturers Depend on Emerging Markets to Increase Sales Momentum
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Contraceptives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Contraceptives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Contraceptives by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Female by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Female by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Female by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Male by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Male by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Male by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Household by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Household by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Household by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 25: World Contraceptives Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Contraceptives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2014, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2014, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • JAPAN
    • Contraceptives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2014, 2024 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • CHINA
    • Contraceptives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2014, 2024 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2014, 2024 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • EUROPE
    • Contraceptives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Contraceptives by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Contraceptives by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Contraceptives by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • FRANCE
    • Contraceptives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: France 16-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2014, 2024 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2014, 2024 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • GERMANY
    • Contraceptives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Germany 16-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2014, 2024 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2014, 2024 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Italy 16-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2014, 2024 & 2030
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2014, 2024 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Contraceptives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 101: UK Recent Past, Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: UK 16-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2014, 2024 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2014, 2024 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 110: Spain Recent Past, Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Spain Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Spain 16-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2014, 2024 & 2030
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Spain 16-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2014, 2024 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 119: Russia Recent Past, Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Russia Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Russia 16-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2014, 2024 & 2030
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Russia 16-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2014, 2024 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Europe 16-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2014, 2024 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Contraceptives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Contraceptives by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Contraceptives by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Asia-Pacific 16-Year Perspective for Contraceptives by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2014, 2024 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2014, 2024 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Contraceptives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 149: Australia Recent Past, Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Australia Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Australia 16-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2014, 2024 & 2030
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Australia 16-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2014, 2024 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • INDIA
    • Contraceptives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 158: India Recent Past, Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: India Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: India 16-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2014, 2024 & 2030
    • TABLE 161: India Recent Past, Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: India 16-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2014, 2024 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: India 16-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 167: South Korea Recent Past, Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: South Korea Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: South Korea 16-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2014, 2024 & 2030
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: South Korea 16-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2014, 2024 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 176: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Rest of Asia-Pacific Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Rest of Asia-Pacific 16-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2014, 2024 & 2030
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2014, 2024 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Contraceptives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 185: Latin America Recent Past, Current & Future Analysis for Contraceptives by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 186: Latin America Historic Review for Contraceptives by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Latin America 16-Year Perspective for Contraceptives by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Latin America 16-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2014, 2024 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2014, 2024 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 197: Argentina Recent Past, Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Argentina Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Argentina 16-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2014, 2024 & 2030
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Argentina 16-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2014, 2024 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Argentina 16-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 206: Brazil Recent Past, Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Brazil Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Brazil 16-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2014, 2024 & 2030
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Brazil 16-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2014, 2024 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Brazil 16-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 215: Mexico Recent Past, Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Mexico Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Mexico 16-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2014, 2024 & 2030
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: Mexico 16-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2014, 2024 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 223: Mexico 16-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 224: Rest of Latin America Recent Past, Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Rest of Latin America Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 226: Rest of Latin America 16-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2014, 2024 & 2030
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 229: Rest of Latin America 16-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2014, 2024 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 232: Rest of Latin America 16-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Contraceptives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 233: Middle East Recent Past, Current & Future Analysis for Contraceptives by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 234: Middle East Historic Review for Contraceptives by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 235: Middle East 16-Year Perspective for Contraceptives by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 238: Middle East 16-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2014, 2024 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2014, 2024 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 245: Iran Recent Past, Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Iran Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 247: Iran 16-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2014, 2024 & 2030
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 250: Iran 16-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2014, 2024 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 253: Iran 16-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 254: Israel Recent Past, Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Israel Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 256: Israel 16-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2014, 2024 & 2030
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 259: Israel 16-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2014, 2024 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 262: Israel 16-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 263: Saudi Arabia Recent Past, Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Saudi Arabia Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 265: Saudi Arabia 16-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2014, 2024 & 2030
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 268: Saudi Arabia 16-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2014, 2024 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 271: Saudi Arabia 16-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 272: UAE Recent Past, Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 273: UAE Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 274: UAE 16-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2014, 2024 & 2030
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 277: UAE 16-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2014, 2024 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 280: UAE 16-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 281: Rest of Middle East Recent Past, Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 282: Rest of Middle East Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 283: Rest of Middle East 16-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2014, 2024 & 2030
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 286: Rest of Middle East 16-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2014, 2024 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 289: Rest of Middle East 16-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2014, 2024 & 2030
  • AFRICA
    • Contraceptives Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 290: Africa Recent Past, Current & Future Analysis for Contraceptives by Product Type - Drugs and Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Africa Historic Review for Contraceptives by Product Type - Drugs and Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 292: Africa 16-Year Perspective for Contraceptives by Product Type - Percentage Breakdown of Value Sales for Drugs and Devices for the Years 2014, 2024 & 2030
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Contraceptives by Gender - Female and Male - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Contraceptives by Gender - Female and Male Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 295: Africa 16-Year Perspective for Contraceptives by Gender - Percentage Breakdown of Value Sales for Female and Male for the Years 2014, 2024 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Contraceptives by End-Use - Household, Hospitals and Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Contraceptives by End-Use - Household, Hospitals and Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 298: Africa 16-Year Perspective for Contraceptives by End-Use - Percentage Breakdown of Value Sales for Household, Hospitals and Clinics for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제